ITI-1284
- Generic Name
- ITI-1284
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Phase 2
Recruiting
- Conditions
- Agitation Associated With Alzheimer's Dementia
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Intra-Cellular Therapies, Inc.
- Target Recruit Count
- 320
- Registration Number
- NCT06651567
- Locations
- 🇺🇸
Clinical Site, Round Rock, Texas, United States
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Phase 2
Recruiting
- Conditions
- Psychosis Associated With Alzheimer's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Intra-Cellular Therapies, Inc.
- Target Recruit Count
- 370
- Registration Number
- NCT06540833
- Locations
- 🇺🇸
Clinical Site, Toms River, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath